Risk factors for mortality in children with diabetic keto acidosis from developing countries

Varadarajan Poovazhagi1

  • 1Varadarajan Poovazhagi, Government Raja Mirasdar Hospital, Thanjavur Medical College, Thanjavur 613001, India.

World Journal of Diabetes
|December 17, 2014
PubMed

Insights

Diabetic ketoacidosis (DKA) in children is a significant cause of mortality, particularly in developing nations. Increased awareness and early diagnosis are crucial to reduce high DKA-related death rates.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Diabetic ketoacidosis (DKA) is a critical complication of Diabetes Mellitus (DM), especially in children.
  • Type 1 DM incidence is rising globally, with a concerning shift towards younger age groups.
  • Mortality rates for DKA remain alarmingly high in developing countries compared to developed nations.

Purpose of the Study:

  • To highlight the disparities in DKA mortality between developed and developing countries.
  • To identify factors contributing to increased DKA mortality in children from developing regions.
  • To emphasize the need for enhanced health education and awareness regarding DM/DKA symptoms.

Main Methods:

  • Review of existing literature and retrospective studies on DKA in children.
  • Analysis of mortality rates and associated complications in DKA cases.
  • Comparison of DKA management and outcomes in developed versus developing countries.

Main Results:

  • Developing countries report higher DKA mortality rates, with increased incidence of cerebral edema, sepsis, shock, and renal failure.
  • Delayed diagnosis is identified as a primary factor contributing to severe complications and mortality.
  • Successful DKA prevention strategies have been demonstrated through public and physician awareness initiatives.

Conclusions:

  • Urgent need for targeted health education to improve early DM/DKA detection in children.
  • Implementing awareness campaigns can significantly reduce DKA-related mortality and morbidity.
  • Addressing delayed diagnosis is paramount to improving outcomes for children with DKA in resource-limited settings.

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic...
4
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
1
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
6
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
2
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.9K